1. Home
  2. HNI vs VKTX Comparison

HNI vs VKTX Comparison

Compare HNI & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HNI Corporation

HNI

HNI Corporation

N/A

Current Price

$48.15

Market Cap

3.6B

ML Signal

N/A

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

N/A

Current Price

$24.95

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HNI
VKTX
Founded
1944
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.7B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
HNI
VKTX
Price
$48.15
$24.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
21
Target Price
$73.88
★ $95.32
AVG Volume (30 Days)
450.8K
★ 3.8M
Earning Date
11-03-2026
10-28-2026
Dividend Yield
★ 2.90%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.40
N/A
Revenue
★ $2,839,000,000.00
N/A
Revenue This Year
$109.72
N/A
Revenue Next Year
$3.04
N/A
P/E Ratio
$34.49
★ N/A
Revenue Growth
★ 12.37
N/A
52 Week Low
$28.93
$23.82
52 Week High
$52.79
$43.10

Technical Indicators

Market Signals
Indicator
HNI
VKTX
Relative Strength Index (RSI) 50.28 40.45
Support Level $45.40 $23.82
Resistance Level $48.28 $36.01
Average True Range (ATR) 1.92 1.82
MACD -0.10 -0.10
Stochastic Oscillator 33.56 0.56

Price Performance

Historical Comparison
HNI
VKTX

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: